10.1002/ana.410330203 176 PrineasJ
F.CostaI.TeixeiraV.SilvaR.BarbosaD
J., Ma, H., Xu, W., Lv, R., Li, X., Villen, J., Gygi, S
More large-scale, long-term randomised controlled trials are needed to validate these results and explore NAC and GSHs long-term therapeutic potential in managing PD
Key finding: Ipamorelin increased lean body mass by 2.1kg, reduced fat mass by 2.7kg, improved body composition ratio by 18%
The data matrices obtained from GC-MS were normalized to the total peak area and transferred to the SIMCA-P+ (v13.0, Umetrics, Umea, Sweden) program for multivariate analysis such as principal component analysis (PCA) and partial least squares differentiation analysis (PLS-DA) for the assessment of separability of the groups